RT Journal Article
SR Electronic
T1 Choosing the right tool for the job: A comprehensive assessment of serological assays for SARS-CoV-2 as surrogates for authentic virus neutralization
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.14.21255399
DO 10.1101/2021.04.14.21255399
A1 Wohlgemuth, Nicholas
A1 Whitt, Kendall
A1 Cherry, Sean
A1 Roubidoux, Ericka Kirkpatrick
A1 Lin, Chun-Yang
A1 Allison, Kim J.
A1 Gowen, Ashleigh
A1 Freiden, Pamela
A1 Allen, E. Kaitlynn
A1 ,
A1 Gaur, Aditya H.
A1 Estepp, Jeremie H.
A1 Tang, Li
A1 Mori, Tomi
A1 Hijano, Diego R.
A1 Hakim, Hana
A1 McGargill, Maureen A.
A1 Krammer, Florian
A1 Whitt, Michael A.
A1 Wolf, Joshua
A1 Thomas, Paul G.
A1 Schultz-Cherry, Stacey
YR 2021
UL http://medrxiv.org/content/early/2021/04/20/2021.04.14.21255399.abstract
AB Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and has since caused a global pandemic resulting in millions of cases and deaths1-4. Diagnostic tools and serological assays are critical for controlling the outbreak5-7, especially assays designed to quantitate neutralizing antibody levels, considered the best correlate of protection8-11. As vaccines become increasingly available12, it is important to identify reliable methods for measuring neutralizing antibody responses that correlate with authentic virus neutralization but can be performed outside of biosafety level 3 (BSL3) laboratories. While many neutralizing assays using pseudotyped virus have been developed, there have been few studies comparing the different assays to each other as surrogates for authentic virus neutralization9,10,13,14. Here we characterized three enzyme-linked immunosorbent assays (ELISAs) and three pseudotyped VSV virus neutralization assays and assessed their concordance with authentic virus neutralization. The most accurate assays for predicting authentic virus neutralization were luciferase and secreted embryonic alkaline phosphatase (SEAP) expressing pseudotyped virus neutralizations, followed by GFP expressing pseudotyped virus neutralization, and then the ELISAs.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was funded by ALSAC, the NIAID for the St. Jude Center of Excellence for Influenza Research and Surveillance (CEIRS contract HHSN27220140006C) and the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00052, and by the University of Tennessee Research Foundation. JHE is supported by the American Society of Hematology Scholar Award. Work in the Krammer laboratory is partially funded by the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) contract 75N93019C00051, NIAID Center of Excellence for Influenza Research and Surveillance (CEIRS, contract # HHSN272201400008C), by the generous support of the Cohen Foundation, the JPB Foundation and the Open Philanthropy Project (research grant 2020-215611 (5384), and by anonymous donors. No authors or their institutions received payment or services from a third party for any aspect of the submitted work.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The samples collected and used in this study were approved by the St Jude Children's Research Hospital IRB. All samples were deidentified and lab members do not have the code.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available in the manuscript.